Canlyniadau Chwilio - Chowdhary, Sajeel

Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis gan Chowdhary, Sajeel A., Ryken, Timothy, Newton, Herbert B.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

ACTR-26. A FEASIBILITY STUDY OF THE NATIVIS VOYAGER® SYSTEM IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM) gan Barkhoudarian, Garni, Chowdhary, Sajeel, Blondin, Nicholas, Kesari, Santosh

Cael y testun llawn Cael y testun llawn

ACTR-69. FEASIBILITY STUDY OF THE EMULATE THERAPEUTICS™ VOYAGER SYSTEM IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA gan Barkhoudarian, Garni, Blondin, Nicholas, Chowdhary, Sajeel, Fonkem, Ekokobe, Vaillant, Brian, Kesari, Santosh

Cael y testun llawn Cael y testun llawn

A prospective phase II single-institution trial of sunitinib for recurrent malignant glioma gan Pan, Edward, Yu, Daohai, Yue, Binglin, Potthast, Lisa, Chowdhary, Sajeel, Smith, Pamela, Chamberlain, Marc

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Myelopathy from Intradural Extramedullary Metastasis as an Initial Presentation of Metastatic Melanoma gan Stein, Alan A, Weinstein, Gila R, Niezgoda, Colin, Chowdhary, Sajeel, Vrionis, Frank, Houten, John K

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Case Reports of Pembrolizumab-induced Acute Inflammatory Demyelinating Polyneuropathy gan Manam, Rupesh, Martin, Jasmine L, Gross, Joshua A, Chaudhary, Dhishna, Chowdhary, Sajeel, Espinosa, Patricio S, Santos, Edgardo S

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Phase I trial of vorinostat combined with bevacizumab and CPT-11 in recurrent glioblastoma gan Chinnaiyan, Prakash, Chowdhary, Sajeel, Potthast, Lisa, Prabhu, Antony, Tsai, Ya-Yu, Sarcar, Bhaswati, Kahali, Soumen, Brem, Steven, Yu, H. Michael, Rojiani, Amyn, Murtagh, Ryan, Pan, Edward

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Feasibility, phase I, and phase II studies of tandutinib, an oral platelet-derived growth factor receptor-β tyrosine kinase inhibitor, in patients with recurrent glioblastoma gan Batchelor, Tracy T., Gerstner, Elizabeth R., Ye, Xiaobu, Desideri, Serena, Duda, Daniel G., Peereboom, David, Lesser, Glenn J., Chowdhary, Sajeel, Wen, Patrick Y., Grossman, Stuart, Supko, Jeffrey G.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Analgesic Use and the Risk of Primary Adult Brain Tumor gan Egan, Kathleen M., Nabors, L. Burton, Thompson, Zachary J., Rozmeski, Carrie M., Anic, Gabriella A., Olson, Jeffrey J., LaRocca, Renato V., Chowdhary, Sajeel A., Forsyth, Peter A., Thompson, Reid C.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Handedness and the Risk of Glioma gan Miller, Briana, Peeri, Noah C., Nabors, L. Burt, Creed, Jordan H., Thompson, Zachary J., Rozmeski, Carrie M., LaRocca, Renato V., Chowdhary, Sajeel, Olson, Jeffrey J., Thompson, Reid C., Egan, Kathleen M.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

ACTR-68. FEASIBILITY STUDY OF THE EMULATE THERAPEUTICS™ VOYAGER SYSTEM IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM) gan Barkhoudarian, Garni, Badruddoja, Michael, Blondin, Nicholas, Chen, Ricky, Chowdhary, Sajeel, Cobbs, Charles, Dowling, Anthony, Duic, Paul, Paul Flores, John, Fonkem, Ekokobe, McClay, Edward, Nabors, Louis, Salacz, Michael, Vaillant, Brian, Kesari, Santosh

Cael y testun llawn Cael y testun llawn

Toenail selenium, genetic variation in selenoenzymes and risk and outcome in glioma gan Peeri, Noah C., Creed, Jordan, Anic, Gabriella M., Thompson, Reid C., Olson, Jeffrey J., LaRocca, Renato V., Chowdhary, Sajeel A., Brockman, John D., Gerke, Travis A., Nabors, L. Burton, Egan, Kathleen M.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Older age at the completion of linear growth is associated with an increased risk of adult glioma gan Little, Rebecca B., Nabors, L. Burt, Olson, Jeffrey J., Thompson, Zachary J., Rozmeski, Carrie M., LaRocca, Renato V., Forsyth, Peter A., Thompson, Reid C., Oster, Robert A., Chowdhary, Sajeel A., Egan, Kathleen M.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Methylmercury exposure, genetic variation in metabolic enzymes, and the risk of glioma gan Creed, Jordan H., Peeri, Noah C., Anic, Gabriella M., Thompson, Reid C., Olson, Jeffrey J., LaRocca, Renato V., Chowdhary, Sajeel A., Brockman, John D., Gerke, Travis A., Nabors, Louis B., Egan, Kathleen M.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

ATIM-30. COMBATING RECURRENT GLIOBLASTOMA WITH MDNA55, AN INTERLEUKIN-4 RECEPTOR TARGETED IMMUNOTHERAPY, THROUGH MRI-GUIDED CONVECTIVE DELIVERY gan Sampson, John, Singh Achrol, Achal, Aghi, Manish, Bankiewicz, Krystof, Brem, Steven, Brenner, Andrew, Butowski, Nicholas, Chandhasin, Chandtip, Chowdhary, Sajeel, Coello, Melissa, Floyd, John R, Kesari, Santosh, Merchant, Fahar, Merchant, Nina, Randazzo, Dina, Vogelbaum, Michael, Vrionis, Frank, Zabek, Miroslaw, Bexon, Martin

Cael y testun llawn Cael y testun llawn

CTIM-13. CLINICAL EFFICACY OF MDNA55, AN INTERLEUKIN-4 RECEPTOR TARGETED IMMUNOTHERAPY, IN RECURRENT GBM DELIVERED BY CONVECTION ENHANCED DELIVERY (CED) gan Sampson, John, Achrol, Achal, Aghi, Manish, Bankiewiecz, Krystof, Bexon, Martin, Brem, Steven, Brenner, Andrew, Chandhasin, Chandtip, Chowdhary, Sajeel, Coello, Melissa, Ellingson, Benjamin, Floyd, John, Han, Seunggu, Kesari, Santosh, Merchant, Fahar, Merchant, Nina, Randazzo, Dina, Vogelbaum, Michael, Vrionis, Frank, Zabek, Miroslaw, Butowski, Nicholas

Cael y testun llawn Cael y testun llawn

CTIM-28. MDNA55, AN INTERLEUKIN-4 RECEPTOR TARGETED IMMUNOTHERAPY, FOR RECURRENT GBM DELIVERED BY CONVECTION ENHANCED DELIVERY (CED) gan Sampson, John, Achrol, Achal Singh, Aghi, Manish K, Bankiewiecz, Krystof, Bexon, Martin, Brem, Steven, Brenner, Andrew, Chandhasin, Chandtip, Chowdhary, Sajeel, Coello, Melissa, Ellingson, Benjamin, Floyd, John, Han, Seunggu, Kesari, Santosh, Merchant, Fahar, Merchant, Nina, Randazzo, Dina, Vogelbaum, Michael, Vrionis, Frank, Zabek, Miroslaw, Butowski, Nicholas

Cael y testun llawn Cael y testun llawn

Modified RANO (mRANO), iRANO, and standard RANO response to convection-enhanced delivery of IL4R-targeted immunotoxin MDNA55 in recurrent glioblastoma gan Ellingson, Benjamin M., Sampson, John, Achrol, Achal Singh, Aghi, Manish K., Bankiewicz, Krystof, Wang, Chencai, Bexon, Martin, Brem, Steven, Brenner, Andrew, Chowdhary, Sajeel, Floyd, John R., Han, Seunggu, Kesari, Santosh, Randazzo, Dina, Vogelbaum, Michael A., Vrionis, Frank, Zabek, Miroslaw, Butowski, Nicholas, Coello, Melissa, Merchant, Nina, Merchant, Fahar

Cael y testun llawn Cael y testun llawn Cael y testun llawn

GENE-47. EVALUATING GLIOMA RISK ASSOCIATED WITH EXTENT OF EUROPEAN ADMIXTURE IN AFRICAN-AMERICANS AND LATINOS gan Ostrom, Quinn, Egan, Kathleen, Nabors, Burt, Amos, Christopher, Armstrong, Georgina, Bernstein, Jonine, Chowdhary, Sajeel, Claus, Elizabeth, Eckel-Passow, Jeanette, Gerke, Travis, Houlston, Richard, Il’yasova, Dora, Jenkins, Robert, Johansen, Christoffer, Lachance, Daniel, Lai, Rose, LaRocca, Renato, Lau, Ching, Merrell, Ryan, Olson, Jeffrey J, Olson, Sara, Sadetzki, Siegal, Schildkraut, Joellen, Shete, Sanjay, Thompson, Reid, Wrensch, Margaret, Wiencke, John, Melin, Beatrice, Bondy, Melissa, Barnholtz-Sloan, Jill

Cael y testun llawn Cael y testun llawn

Glioma risk associated with extent of estimated European genetic ancestry in African-Americans and Hispanics gan Ostrom, Quinn T., Egan, Kathleen M., Nabors, L. Burt, Gerke, Travis, Thompson, Reid C., Olson, Jeffrey J., LaRocca, Renato, Chowdhary, Sajeel, Eckel-Passow, Jeanette E., Armstrong, Georgina, Wiencke, John K., Bernstein, Jonine L., Claus, Elizabeth B., Il'yasova, Dora, Johansen, Christoffer, Lachance, Daniel H., Lai, Rose K., Merrell, Ryan T., Olson, Sara H., Sadetzki, Siegal, Schildkraut, Joellen M., Shete, Sanjay, Houlston, Richard S., Jenkins, Robert B., Wrensch, Margaret R., Melin, Beatrice, Amos, Christopher I., Huse, Jason T., Barnholtz-Sloan, Jill S., Bondy, Melissa L.

Cael y testun llawn Cael y testun llawn Cael y testun llawn